Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error

被引：0

作者：

M Shipitsin

C Small

S Choudhury

E Giladi

S Friedlander

J Nardone

S Hussain

A D Hurley

C Ernst

Y E Huang

H Chang

T P Nifong

D L Rimm

J Dunyak

M Loda

D M Berman

P Blume-Jensen

机构：

[1] Metamark Genetics Inc.,Department of Pathology

[2] Yale University Medical School,Department of Pathology

[3] Dana Farber Cancer Institute,Department of Pathology and Molecular Medicine and Queen’s Cancer Research Institute

[4] Harvard Medical School,undefined

[5] Queen’s University,undefined

[6] Present address: Karyopharm Therapeutics,undefined

[7] Natick,undefined

[8] MA 01760,undefined

[9] USA.,undefined

来源：

British Journal of Cancer | 2014年 / 111卷

关键词：

prostate cancer; biopsy; biomarkers; prognosis; sampling error; tumour heterogeneity;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1201 / 1212

页数：11

共 29 条

[21] Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers
Ferro, Matteo
Bruzzese, Dario
Perdona, Sisto
Mazzarella, Claudia
Marino, Ada
Sorrentino, Alessandra
Di Carlo, Angelina
Autorino, Riccardo
Di Lorenzo, Giuseppe
Buonerba, Carlo
Altieri, Vincenzo
Mariano, Angela
Macchia, Vincenzo
Terracciano, Daniela
CLINICA CHIMICA ACTA, 2012, 413 (15-16) : 1274 - 1278
[22] PREDICTING PROSTATE BIOPSY OUTCOME: PROSTATE HEALTH INDEX (PHI) AND PROSTATE CANCER ANTIGEN 3 (PCA3) ARE USEFUL BIOMARKERS
Ferro, Matteo
Montanaro, Vittorino
Marsicano, Mariano
Capece, Marco
Terracciano, Daniela
Sorrentino, Alessandra
Marino, Ada
Quarto, Giuseppe
De Domenico, Renato
Sorrentino, Domenico
Altieri, Vincenzo
Perdona, Sisto
ANTICANCER RESEARCH, 2012, 32 (05) : 1940 - 1941
[23] A prospective study to validate an algorithm using urine and plasma biomarkers for predicting high-risk prostate cancer on biopsy
Mortensen, Mike A.
Feddersen, Soren
Albitar, Maher
Lund, Lars
SCANDINAVIAN JOURNAL OF UROLOGY, 2017, 51 : 24 - 24
[24] IDENTIFICATION OF RACE-SPECIFIC BIOMARKERS FOR PROSTATE CANCER PROGRESSION FROM FORMALIN-FIXED BIOPSY TISSUE.
Petros, John
Arnold, Rebecca
Xu, Jianpeng
Long, Qi
Sannigrahi, Soma
Park, Jong
Osunkoya, Adeboye
Moreno, Carlos
JOURNAL OF UROLOGY, 2016, 195 (04): : E10 - E11
[25] Quantitative SWATH-Based Proteomic Profiling for Identification of Mechanism-Driven Diagnostic Biomarkers Conferring in the Progression of Metastatic Prostate Cancer
Singh, Anshika N.
Sharma, Neeti
FRONTIERS IN ONCOLOGY, 2020, 10
[26] Parafilm-assisted microdissection: a sampling method for mass spectrometry-based identification of differentially expressed prostate cancer protein biomarkers
Quanico, J.
Franck, J.
Gimeno, J. P.
Sabbagh, R.
Salzet, M.
Day, R.
Fournier, I.
CHEMICAL COMMUNICATIONS, 2015, 51 (22) : 4564 - 4567
[27] A Multi-Center Prospective Study to Validate an Algorithm Using Urine and Plasma Biomarkers for Predicting Gleason ≥3+4 Prostate Cancer on Biopsy
Albitar, Maher
Ma, Wanlong
Lund, Lars
Shahbaba, Babak
Uchio, Edward
Feddersen, Soren
Moylan, Donald
Wojno, Kirk
Shore, Neal
JOURNAL OF CANCER, 2017, 8 (13): : 2554 - 2560
[28] Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach
Lei Chang
Jie Ni
Julia Beretov
Valerie C. Wasinger
Jingli Hao
Joseph Bucci
David Malouf
David Gillatt
Peter H. Graham
Yong Li
Scientific Reports, 7
[29] Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach
Chang, Lei
Ni, Jie
Beretov, Julia
Wasinger, Valerie C.
Hao, Jingli
Bucci, Joseph
Malouf, David
Gillatt, David
Graham, Peter H.
Li, Yong
SCIENTIFIC REPORTS, 2017, 7

← 1 2 3 →